仕佳光子(688313.SH):1.6T光模塊用AWG芯片及組件、MT-FA產品部分型號已通過客戶驗證並實現小批量出貨
格隆匯6月10日丨仕佳光子(688313.SH)在投資者互動平臺表示,公司1.6T光模塊用AWG芯片及組件、MT-FA產品部分型號已通過客戶驗證並實現小批量出貨;800G多芯數高密度光纜連接器(MMC/SNMT)實現小批量出貨。隨着數據中心、雲計算等領域的不斷髮展,對高速率、高密度的光連接產品需求日益旺盛。公司將繼續加大研發投入,不斷提升產品性能和質量,以更好地滿足市場需求,把握市場機遇。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.